BioLineRx is a clinical-stage biopharmaceutical company based in Jerusalem, Israel. BioLineRx’s aim is to develop products to address unmet medical needs, as well as products with the potential benefit above current therapies. BioLineRx has five clinical therapeutics candidates in its development pipeline for the treatment of schizophrenia; prevention of cardiac remodeling in Acute Myocardial Infarction patients; a formulation for non-surgical removal of skin lesions; treatment for neuropathic pain; and treatment of inflammatory bowel disease. The company has 13 additional compounds currently in the pipeline at various stages of pre-clinical development. For more information visit the company’s Web site at www.biolinerx.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below: